{"id":"https://openalex.org/W2004565378","doi":"https://doi.org/10.1111/j.1365-2141.2005.05600.x","title":"Control of advanced and refractory acute myelogenous leukaemia with sirolimus\u2010based non\u2010myeloablative allogeneic stem cell transplantation","display_name":"Control of advanced and refractory acute myelogenous leukaemia with sirolimus\u2010based non\u2010myeloablative allogeneic stem cell transplantation","publication_year":2005,"publication_date":"2005-07-01","ids":{"openalex":"https://openalex.org/W2004565378","doi":"https://doi.org/10.1111/j.1365-2141.2005.05600.x","mag":"2004565378","pmid":"https://pubmed.ncbi.nlm.nih.gov/16029454"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.2005.05600.x","doi":"https://doi.org/10.1111/j.1365-2141.2005.05600.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2005.05600.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004302802","display_name":"David F. Claxton","orcid":"https://orcid.org/0000-0001-9209-2405","observed_orcids":["https://orcid.org/0000-0001-9209-2405"]},"institutions":[{"id":"https://openalex.org/I4405268258","display_name":"Penn State Cancer Institute","ror":"https://ror.org/00bzx1854","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405268258"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David F. Claxton","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA. dclaxton@psu.edu","Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA. dclaxton@psu.edu","institution_ids":["https://openalex.org/I4405268258","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA","institution_ids":["https://openalex.org/I82783531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076439728","display_name":"Christopher W. Ehmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Ehmann","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA","institution_ids":["https://openalex.org/I82783531"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059838967","display_name":"Witold B. Rybka","orcid":"https://orcid.org/0000-0003-0396-5804","observed_orcids":["https://orcid.org/0000-0003-0396-5804"]},"institutions":[{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Witold Rybka","raw_affiliation_strings":["Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA","institution_ids":["https://openalex.org/I82783531"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004302802"],"corresponding_institution_ids":["https://openalex.org/I4405268258","https://openalex.org/I82783531"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":2.5596,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.88862347,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"130","issue":"2","first_page":"256","last_page":"264"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.01720000058412552,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12900","display_name":"Organ and Tissue Transplantation Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.968999981880188},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.9610000252723694},{"id":"https://openalex.org/keywords/nonmyeloablative-conditioning","display_name":"nonmyeloablative conditioning","score":0.9929999709129333},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9369999766349792},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.8999999761581421},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8019999861717224},{"id":"https://openalex.org/keywords/haploidentical-transplantation","display_name":"haploidentical transplantation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/unrelated-donor-transplantation","display_name":"unrelated donor transplantation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/refractory-leukemia","display_name":"refractory leukemia","score":0.7519999742507935},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.6660000085830688},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6539999842643738},{"id":"https://openalex.org/keywords/donor-lymphocyte-infusion","display_name":"donor lymphocyte infusion","score":0.8690000176429749},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8305194973945618},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6252481937408447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5912261605262756},{"id":"https://openalex.org/C2777921159","wikidata":"https://www.wikidata.org/wiki/Q32089","display_name":"Sirolimus","level":2,"score":0.5884540677070618},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.5870646238327026},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.5821929574012756},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5630103349685669},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.5386947989463806},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.5314793586730957},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.48648661375045776},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4693532884120941},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.46179744601249695},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.444791316986084}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006085","descriptor_name":"Graft Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2141.2005.05600.x","doi":"https://doi.org/10.1111/j.1365-2141.2005.05600.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2005.05600.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:16029454","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16029454","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W24911164","https://openalex.org/W1479909146","https://openalex.org/W1491993932","https://openalex.org/W1616716935","https://openalex.org/W1883328448","https://openalex.org/W1969360151","https://openalex.org/W1972674500","https://openalex.org/W2007757672","https://openalex.org/W2008150461","https://openalex.org/W2019326887","https://openalex.org/W2021727607","https://openalex.org/W2025457437","https://openalex.org/W2026351725","https://openalex.org/W2030452018","https://openalex.org/W2036763148","https://openalex.org/W2038204317","https://openalex.org/W2046464784","https://openalex.org/W2047260189","https://openalex.org/W2049783422","https://openalex.org/W2064353818","https://openalex.org/W2075270208","https://openalex.org/W2080048865","https://openalex.org/W2080986723","https://openalex.org/W2082167435","https://openalex.org/W2087591188","https://openalex.org/W2090992688","https://openalex.org/W2092808890","https://openalex.org/W2106947293","https://openalex.org/W2117648349","https://openalex.org/W2119845492","https://openalex.org/W2128912851","https://openalex.org/W2130223796","https://openalex.org/W2131706663","https://openalex.org/W2136016420","https://openalex.org/W2154928424","https://openalex.org/W2162636536","https://openalex.org/W2333943209","https://openalex.org/W2411423468","https://openalex.org/W2992506450"],"related_works":["https://openalex.org/W2568397713","https://openalex.org/W2143732243","https://openalex.org/W2083591652","https://openalex.org/W2587200223","https://openalex.org/W2580515099","https://openalex.org/W4205169040","https://openalex.org/W2564168911","https://openalex.org/W2141980370","https://openalex.org/W2329784507","https://openalex.org/W1972674500"],"abstract_inverted_index":{"Non-myeloablative":[0],"conditioning":[1],"has":[2],"extended":[3],"the":[4,17],"use":[5],"of":[6,29,52,66,115,119,136,145,155],"allogeneic":[7],"haematopoietic":[8,187],"transplant":[9,27],"to":[10,24,83,96],"many":[11],"previously":[12],"ineligible":[13],"patients.":[14],"We":[15],"added":[16],"immunosuppressive":[18],"and":[19,37,43,47,91,109,163,166,173,206],"antitumour":[20],"agent":[21],"sirolimus":[22,191],"(rapamycin)":[23],"an":[25],"established":[26],"regimen":[28],"fludarabine":[30],"25":[31],"mg/m(2)":[32,40],"days":[33,41],"-7":[34,42],"through":[35],"-3":[36],"cyclophosphamide":[38],"1000":[39],"-6,":[44],"with":[45,55,62,190,204],"tacrolimus":[46],"methotrexate":[48],"immunoprophyllaxis.":[49],"A":[50],"total":[51,77],"23":[53,146],"patients":[54,75,86,100,130,147,203],"acute":[56],"myelogenous":[57],"leukaemia":[58],"(AML)":[59],"were":[60,78,87,93,168],"treated,":[61],"a":[63],"median":[64],"age":[65],"59":[67],"years":[68,200],"(range:":[69],"28-72)":[70],"at":[71,149,159],"transplant.":[72],"Only":[73,132],"seven":[74,92],"in":[76,79,88,169,201],"complete":[80],"remission":[81,170],"prior":[82],"transplantation.":[84],"Nine":[85],"chemotherapy-refractory":[89],"progression":[90],"primarily":[94],"refractory":[95],"induction":[97],"therapy.":[98],"Six":[99],"received":[101,126],"matched":[102,108],"sibling,":[103],"11":[104],"unrelated":[105],"donor,":[106],"1-5/6":[107],"five":[110],"haploidentical":[111,137],"(haplo":[112],"-":[113],"three":[114,167],"six":[116,120],"or":[117],"four":[118],"matched)":[121],"transplants.":[122],"The":[123],"haplo-recipients":[124],"also":[125],"antithymocyte":[127],"globulin,":[128],"all":[129],"engrafted.":[131],"two,":[133],"both":[134],"recipients":[135],"cells,":[138],"have":[139],"died":[140],"from":[141],"transplant-related":[142],"causes.":[143],"Twelve":[144],"survived":[148],"198-1162-d":[150],"post-transplant":[151],"(median":[152],"578).":[153],"Four":[154],"12":[156],"survivors":[157],"relapsed":[158],"83,":[160],"88,":[161],"243":[162],"508":[164],"d":[165],"after":[171],"chemotherapy":[172],"donor":[174],"lymphocyte":[175],"infusion.":[176],"Although":[177],"follow":[178],"up":[179],"is":[180],"short,":[181],"this":[182],"data":[183],"suggests":[184],"that":[185],"non-myeloablative":[186],"cell":[188],"transplantation":[189],"(rapamycin)-based":[192],"immunosuppression":[193],"may":[194],"provide":[195],"disease":[196],"control":[197],"over":[198],"several":[199],"some":[202],"advanced":[205],"poor":[207],"prognosis":[208],"AML.":[209]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}